lilly glp 1 drug launches GLP-1 pill, kicking off showdown with Novo Nordisk Lilly's GLP-1 Direct-To-Consumer Move Changes

With the emergence of the gut microbiome in modulating host behavior via various routes (metabolites, neuronal, endocrine, immune system), the microbiota-gut-brain axis has become a key player in the research of different psychopathologies

Notably, GLP-1-RAs have shown potential in inhibiting the proliferation of various cancer cells, including breast, ovarian, pancreatic, and prostate cancers

News Release August 31, 2005 ConsumerLab.com testing of alpha lipoic acid supplements from Japan finds no ingredient in one product

CDC Community Experiences Join the conversation and become a part of our nurturing community